Skip to main content

Osteoarthritis Injection Recalled

July 09, 2020

Flexion Therapeutics Inc. is voluntarily recalling a single lot of Zilretta (triamcinolone acetonide extended-release injectable suspension) kits because the product was stored at room temperature longer than 6 weeks, according to the July 8, 2020, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects Zilretta, 32 mg per vial, 5-mL vials, single-dose kits (NDC 70801-003-01) from lot ZA19014 (Exp. 5/21). The product was distributed throughout the United States.  

Flexion Therapeutics initiated the recall May 19, 2020. The FDA has not yet classified the recall.  

Available with a prescription, Zilretta is an extended-release corticosteroid approved to manage osteoarthritis knee pain.

Jolynn Tumolo

Agree or disagree with an article? Share your professional thoughts on an article you read.

Your Name
2 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Back to Top